Chengdu Kanghua Biological Products (300841) — Cash Flow Quality Index
Chengdu Kanghua Biological Products (300841) has a Cash Flow Quality Index of 1.25x as of September 2025. Operating cash flow of CN¥92.89 Million exceeds net income of CN¥74.59 Million, indicating high earnings quality where cash backs reported profits. Explore Chengdu Kanghua Biological Products operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Chengdu Kanghua Biological Products Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Chengdu Kanghua Biological Products across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Chengdu Kanghua Biological Products investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year earnings quality comparison for Chengdu Kanghua Biological Products. For live market cap and the full company financial profile, see market cap of Chengdu Kanghua Biological Products.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.44x | CN¥572.24 Million | CN¥398.65 Million | ▲ +27.3% |
| 2023 | 1.13x | CN¥573.98 Million | CN¥509.22 Million | ▲ +245.7% |
| 2022 | 0.33x | CN¥194.99 Million | CN¥598.07 Million | ▲ +107.5% |
| 2021 | 0.16x | CN¥130.33 Million | CN¥829.48 Million | ▼ -82.7% |
| 2020 | 0.91x | CN¥369.56 Million | CN¥408.05 Million | ▼ -7.5% |
| 2019 | 0.98x | CN¥182.73 Million | CN¥186.69 Million | ▲ +163.1% |
| 2018 | 0.37x | CN¥57.35 Million | CN¥154.14 Million | ▼ -69.2% |
| 2017 | 1.21x | CN¥89.96 Million | CN¥74.46 Million | ▲ +204.3% |
| 2016 | 0.40x | CN¥2.64 Million | CN¥6.66 Million | ▼ -28.6% |
| 2015 | 0.56x | CN¥6.51 Million | CN¥11.70 Million | — |